Skip to main content

Advertisement

Log in

The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Purpose

This study evaluates the role and outcomes of Gamma Knife radiosurgery (GKRS) in the management of pituitary metastases.

Methods

The records of brain metastases patients who underwent GKRS at the University of Pittsburgh Medical Center during the 10-year interval of 2010–2020 were systematically reviewed. Outcome measures included patient survival, tumor control rate, pituitary hormonal outcomes, visual outcomes, adverse radiation effects (AREs), and need for adjuvant therapy.

Results

Eighteen patients with pituitary metastases (eight male; median age of 65.5 years) had sufficient clinical follow-up for analysis. The most common primary cancers were non-small cell lung cancer (n = 6) and breast cancer (n = 4). Patients presented with headache (n = 9) and visual difficulties (n = 6). One patient underwent resection before GKRS. The median tumor volume was 0.78 cc (range 0.04–6.42 cc). The median overall survival after GKRS was 6.5 months (range 0.5–58 months). The overall survival after GKRS at 3-, 6-, and 12-months were 72.2%, 50.0% and 38.9%, respectively. The tumor control rate was 94.4%. One patient had further progression that required additional GKRS. None of the patients developed AREs after GKRS.

Conclusion

GKRS is an effective treatment modality for the multidisciplinary management of patients with pituitary metastases. This minimally-invasive strategy is associated with optimal tumor control rate and low risk to adjacent optic nerves or neurovascular structures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

All authors confirm the appropriateness of all dataset and software used for supporting the conclusion.

Code availability

Not applicable.

References

  1. McCormick PC et al (1989) Metastatic carcinoma to the pituitary gland. Br J Neurosurg 3(1):71–79

    Article  CAS  PubMed  Google Scholar 

  2. Sioutos P, Yen V, Arbit E (1996) Pituitary gland metastases. Ann Surg Oncol 3(1):94–99

    Article  CAS  PubMed  Google Scholar 

  3. Fassett DR, Couldwell WT (2004) Metastases to the pituitary gland. Neurosurg Focus 16(4):E8

    Article  PubMed  Google Scholar 

  4. Kano H et al (2009) Stereotactic radiosurgery for pituitary metastases. Surg Neurol 72(3):248–55

    Article  PubMed  Google Scholar 

  5. Ng S et al (2020) Current status and treatment modalities in metastases to the pituitary: a systematic review. J Neurooncol 146(2):219–227

    Article  PubMed  Google Scholar 

  6. Habu M et al (2015) Pituitary metastases: current practice in Japan. J Neurosurg 123(4):998–1007

    Article  CAS  PubMed  Google Scholar 

  7. Chon H et al (2017) Hypofractionated stereotactic radiosurgery for pituitary metastases. J Neurooncol 132(1):127–133

    Article  PubMed  Google Scholar 

  8. He W et al (2015) Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 18(1):159–168

    Article  PubMed  Google Scholar 

  9. Max MB, Deck MD, Rottenberg DA (1981) Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 31(8):998–1002

    Article  CAS  PubMed  Google Scholar 

  10. Abou-Al-Shaar H, Faramand A, Zhang X, Mallela AN, Branstetter BF, Wiley CA, Lunsford LD (2021) Chronic encapsulated expanding hematomas after stereotactic radiosurgery for intracranial arteriovenous malformations. J Neurosurg 136(2):492–502

    Article  PubMed  Google Scholar 

  11. Faramand A et al (2019) Primary or salvage stereotactic radiosurgery for brain metastatic small cell lung cancer. J Neurooncol 144(1):217–225

    Article  PubMed  Google Scholar 

  12. Wei Z et al (2022) A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases. J Neurooncol 157(3):417–423

    Article  PubMed  Google Scholar 

  13. Kano H et al (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66(3):486–91

    Article  PubMed  Google Scholar 

  14. Duchen LW (1966) Metastatic carcinoma in the pituitary gland and hypothalamus. J Pathol Bacteriol 91(2):347–355

    Article  CAS  PubMed  Google Scholar 

  15. Gsponer J et al (1999) Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses: retrospective analysis of 353 patients. Medicine (Baltimore) 78(4):236–69

    Article  CAS  Google Scholar 

  16. Teears RJ, Silverman EM (1975) Clinicopathologic review of 88 cases of carcinoma metastatic to the putuitary gland. Cancer 36(1):216–220

    Article  CAS  PubMed  Google Scholar 

  17. Schill F et al (2019) Pituitary metastases: a nationwide study on current characteristics with special reference to breast cancer. J Clin Endocrinol Metab 104(8):3379–3388

    Article  PubMed  Google Scholar 

  18. Al-Aridi R et al (2014) Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review. Pituitary 17(6):575–587

    Article  CAS  PubMed  Google Scholar 

  19. Shimon I (2020) Metastatic Spread to the Pituitary. Neuroendocrinology 110(9–10):805–808

    Article  CAS  PubMed  Google Scholar 

  20. Lin CY et al (2015) Prognostic factors in cancer patients with symptomatic pituitary metastasis: a clinical case study. Anticancer Res 35(2):983–987

    PubMed  Google Scholar 

  21. Javanbakht A et al (2018) Pituitary metastasis: a rare condition. Endocr Connect 7:1049–1057

    Article  PubMed Central  Google Scholar 

  22. Iwai Y et al (2004) Radiosurgery for pituitary metastases. Neurol Med Chir (Tokyo) 44(3):112–116

    Article  Google Scholar 

  23. Benjamin C et al (2020) Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer. Pituitary 23(6):665–671

    Article  PubMed  Google Scholar 

  24. Zoli M et al (2013) Pituitary metastases: role of surgery. World Neurosurg 79(2):327–330

    Article  PubMed  Google Scholar 

  25. Burkhardt T et al (2016) Surgical management of pituitary metastases. Pituitary 19(1):11–18

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

HAAS and LDL designed the study. Material preparation, data collection and analysis were performed by ZW and SY. The first draft of the manuscript was written by ZW and all authors critically revised previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hussam Abou-Al-Shaar.

Ethics declarations

Conflict of interest

Dr. Lunsford is a consultant for Insightec DSMB and has direct stock ownership in Elekta AB. All other authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Ethical approval

The study was approved by the IRB at the University of Pittsburgh Medical Center.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethical Committee at the University of Pittsburgh Medical Center.

Consent to participate

Informed consent was obtained from all participants included in study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, Z., Yavan, S., Deng, H. et al. The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases. Pituitary 25, 948–958 (2022). https://doi.org/10.1007/s11102-022-01279-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-022-01279-z

Keywords

Navigation